On May 27, 2020, in order to inspect the situation of "improving public health infrastructure construction and promoting the development of biomedicine and health industry" in Xiamen, the visiting delegation of CPPCC members went to Xiamen Innodx for field investigation, which was received by Deputy General Manager Li Shicheng and others.
Deputy General Manager Li Shicheng introduced the development history of the company and its representative products, and showed the relevant industry lines through real-time monitoring. Since the outbreak of epidemic, relying on the National Institute of Diagnostics and Vaccine Development in Infectious Diseases (NIDVD) co-founded by Yangshengtang and Xiamen University, Xiamen Innodx plays the advantage of innovative vaccines and in vitro diagnostic in the respects of diagnostic reagents, instruments, and vaccines, actively joins the team of fighting against new corona virus.
On 6th March, first Double Antigen Sandwich Method “Novel coronavirus total antibody diagnostic reagent” in global was approved and came into the market. It has been applied in wuhan Tongji Hospital, Beijing Hospital, Sichuan West China Hospital and other medical entities in China. The fully automatic Chemiluminescence Immunoassay analyzer developed by Xiamen Umic can produce results within maximum 29min, giving full play to the advantages of fast and efficient, and has been included in the list of “Key medical equipment scientific and technological achievements transformation and promotion” by national Ministry of Science and Technology.
The visiting members all recognized the products including HPV vacine and Novel coronavirus total antibody diagnostic reagent, and was confident that with the support of national engineering center, Xiamen Innodx can play a leading role of Haicang Biological Park in the national biopharmaceutical industry.
